Physicians and scientists from Fred Hutch Cancer Center and UW Medicine are constantly researching, developing, and testing new treatments for gynecologic cancers and new ways to use current treatments.
Through this work, we are looking for answers to two main questions: How can we do even better at controlling or curing these diseases? How can we make treatments less toxic and easier on patients?
Immunotherapy — which uses the power of your immune system to fight disease — is transforming care for some cancers. CAR T-cell therapy for blood cancers is one example. Fred Hutch researchers are working on methods to make immunotherapy effective against solid tumors too. We hope to apply new discoveries to tumors like uterine sarcoma in the future.
When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy. Your care team will talk with you about if you might want to join a particular study and why. This can help you make the decision that is best for you.
Gynecologic Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Our Uterine Sarcoma Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat uterine sarcoma as well as other cancers and diseases. The lab research and clinical research they do are essential parts of the scientific process that leads to new treatments and better care. Clinical trials can also be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with gynecologic cancers.
See below for our researchers and faculty or view our uterine sarcoma care team providers.
